【乳癌】利用多模態機器學習預測「乳癌」HR+/HER2-患者接受CDK4/6 抑制劑治療反應

 【乳癌】利用多模態機器學習預測「乳癌」HR+/HER2-患者接受CDK4/6 抑制劑治療反應

 文章出處  

The ASCO Post 

 

 原文標題  

Multimodal integration of real world clinical and genomic data for the prediction of CDK4/6 inhibitors outcomes in patients with HR+/HER2-metastatic breast cancer. 

 

 文章序號  

6864 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.